Hemophilia

Hemophilia


INTRODUCTION:

  • Group of hereditary genetic disorders that impair body’s ability to control blood clotting or coagulation.
TYPES:
1. Based on clotting factor affected:
 
Hemophilia A Deficiency of factor VIII C
Hemophilia B (Christmas disease) Deficiency of factor IX (X-linked)
Hemophilia C Deficiency of factor XI (autosomal inherited defect)
Parahemophilia Deficiency of factor V
 2. Based on severity of condition:
 
Classification

 Distribution

Clotting factor activity

Severe hemophilia

 50%

 <1%

Moderate hemophilia

 10%

 1-5%

Mild hemophilia

 30-40%

 5-40%

ETIOLOGY:

Are sex-linked – 

  • Mainly X chromosome disorder.
  • Manifested almost entirely in males.
  • Females mostly are carriers & inherited from either mother/father.

Haemophilia A – 

  • Due to lack of functional clotting Factor VIII.
  • Bleeding due to lack of reaction accelerator during factor X activation in coagulation cascade.

Haemophilia B – 

  • Bleeding due to lack of functional clotting factor IX.
  • More severe yet, less common than Hemophilia A.

Haemophilia C – 

  • Autosomal recessive genetic disorder.
  • Bleeding due to lack of functional clotting Factor XI.
HEMOPHILIA A:
  • Represents 90% of hemophilia cases.

Based on severity:

  • Mild: 6 – 50 % of normal factor VIII level.
  • Moderate : 1 -5 %
  • Severe: < 1% – Hence, presents with joint synovitis, hemophilic arthropathies, intramuscular bleeding & hemorrhagic cyst.
CLINICAL MANIFESTATIONS:
  • Bleeding can happen anywhere in body following an injury/surgery or spontaneous.
Effects on muscles:
  • Musculoskeletal bleeding
  • Deep bleeding into joints and muscles – Hallmark finding.
  • Begin when child reaches toddler age.
  • In toddlersankle is the most common site.
  • Later, knees & elbow become most common sites.
  • Preceded by an aura. 
  • Develops “Compartment syndrome” – 
  • Hematomas into muscles of distal part of limbs lead to external compression of arteries, veins or nerves that can evolve into “Compartment syndrome”.
Hemorrhages:
  • Presents with “Exsanguinating” hemorrhage involving almost most regions.

Iliopsoas bleeding:

  • Vague abdominal & upper thigh discomfort.
  • Characteristic gait with hip is flexed & internally rotated.
  • Intracranial hemorrhage- Bleeding into & around oropharyngeal spaces.

     

  • Retroperitoneal hemorrhages accumulate large quantities of blood with formation of masses with calcification & inflammatory tissue reaction(Pseudomotor syndrome).

     

Hematuria- May arise spontaneously. 

Effects on bone:

  • Most common cause of fracture in hemophilic patient – Osteoporosis & Restricted Joint Movement
  • Develops “Hemophilic arthropathy”:
  • When factor VIII< 5%.
  • Also develops, Chronic proliferative synovitis.

Long-term sequelae of multiple bouts of hemarthrosis results in

  • Cartilage damage
  • Subarticular cysts
  • Osteopenia
  • Enlarged epiphyses. 
  • Combination of intercondylar notch widening & widened epiphysis – Characteristics of hemophilia & juvenile rheumatoid arthritis (JRA).
INVESTIGATIONS:

BASIC:

  • Complete  hemogram:
  • TLC – normal
  • DLC – normal
  • Platelet count – normal
  • Coagulation time: Prolonged
  • Hb count – decreased 
  • Bleeding time: Normal.
  • Note: Prolonged in von Willebrand disease.
  • PT – Usually normal.
  • APTT – Prolonged to 23 times.
  • X-ray of joint: Knee joint, Elbow joint & Ankle joint

SPECIAL:

  • Factor VIII assay
  • Synovial Fluid Investigation
  • Carrier state genetic testing

Liver biopsy: 

  • Multiple blood transfusions increase total iron load on body resulting in accumulation of iron-containing pigment in liver.
Prenatal diagnosis:
  • Termination of pregnancy considered if fetus affected.
  • Obtain chorionic villi samples in 10th – 11th gestational week and perform direct genotype testing by PCR.
  • Test duration – 1wk / 2wk.

TREATMENT:

Basis of management –

  • Mainly aims for prevention or as part of treating acute bleeding.

Replacement therapy- 

  • Replacement of factor VIII or IX to hemostatically adequate plasma levels.

Treatment on demand:

  • For mild to moderate haemorrhages – 
  • Achieve factor VIII levels – 30-40 U/dL 
  • Factor IX levels to 30 U/dL.
  • DDAVP(ADH preparation) – Drug used in mild hemophilia.
  • By acting on V2 receptors causing increased factor VIII & vWF release from endothelium.

For life-threatening haemorrhages – 

  • Immediately correct factor level to 100-150 U/dL.
  • Also, maintain level between 80-100 U/dL for 5-7 days followed by vigorous maintenance.
Prophylactic factor VIII therapy:
  • Administered by subcutaneous access port of central venous line.
  • Dose of 20-40 U/kg of factor VIII administered every other day or thrice weekly. 
  • Dose and rate adjusted to ensure maintenance before next infusion by >1U/dL
  • Prevents spontaneous bleeding.
  • Haemorrhages caused by trauma require additional replacement.

In Hemophilia with rheumatoid arthritis – 

  • Analgesic of choice – Acetaminophen.
Exam Question
 
  • Increased total body iron concentration within liver.
  • Biopsy showing large amounts of granular golden- brown pigment which stains blue with Prussian blue stain is suggestive of haemophilia.
  • Haemophilia causes an overgrowth of epiphyses.
  • Prenatal diagnosis of Hemophilia is best done by PCR
  • Prolong APTT with normal PT, BT & platelets with postpartum haemorrhage is suggestive of acquired haemophilia A.
  • Normal platelets, Deficient factor VIII & IX are suggestive findings of hemophilia
  • Hemophilia is associated with X chromosome
  • Hemophilia B is due to deficiency of clotting Factor IX
  • Patients with hemophilia A have bleeding disorder because of lack of reaction accelerator during activation of factor X in coagulation cascade.
  • DDAVP is the drug used in mild hemophilia.
  • A child who bleeds from gums and has swollen knee – probably due to hemophilia
  • Spontaneous muscle bleeding is typically seen in hemophilia
  • Bleeding time may be used to differentiate hemophilia A from von Willebrand disease
  • Recurrent Spontaneous Hemarthrosis is commonly seen in patients with Hemophilia when factor VIII levels are <5%.
  • The most common manifestation of moderate /severe Hemophilia A is Recurrent Hemarthrosis.
  • The most common cause of fracture in a patient with Hemophilia is Osteoporosis and Restricted Joint Movement.
  • Females are mostly carriers and all males are affected in hemophilia.
  • In Hemophilia with Rheumatoid arthritis, analgesic of choice is Acetaminophen.
Don’t Forget to Solve all the previous Year Question asked on Hemophilia

Leave a Reply

Discover more from New

Subscribe now to keep reading and get access to the full archive.

Continue reading

👨‍⚕️
Chat Support